PULMONX CORPORATION Capitalized Computer Software, Impairments
PULMONX CORPORATION (LUNG) reported Capitalized Computer Software, Impairments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CapitalizedComputerSoftwareImpairments1 · last filed 2026-03-10
- PULMONX CORPORATION capitalized computer software, impairments for the quarter ending 2025-12-31 was $0.00.
- PULMONX CORPORATION capitalized computer software, impairments for the quarter ending 2025-09-30 was $0.00.
- PULMONX CORPORATION capitalized computer software, impairments for the quarter ending 2024-12-31 was $0.00.
- PULMONX CORPORATION capitalized computer software, impairments for the quarter ending 2024-09-30 was $0.00.
- PULMONX CORPORATION capitalized computer software, impairments for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PULMONX CORPORATION capitalized computer software, impairments for fiscal 2024 was $1.72M.
- PULMONX CORPORATION capitalized computer software, impairments for fiscal 2023 was $0.00.
| Period end | Capitalized Computer Software, Impairments 3 month | Capitalized Computer Software, Impairments 6 month | Capitalized Computer Software, Impairments 9 month | Capitalized Computer Software, Impairments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $0.00 10-K · filed 2026-03-10 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-01 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $1.70M derived: sum of 3 quarters · filed 2026-03-10 | $1.72M 10-K · filed 2026-03-10 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.70M derived: sum of 2 quarters · filed 2026-03-10 | $1.72M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $1.70M 10-K · filed 2026-03-10 | $1.72M 10-Q · filed 2025-08-01 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $0.00 10-Q · filed 2024-11-01 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |